GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) » Definitions » COGS-to-Revenue

Guangdong Zhongsheng Pharmaceutical Co (SZSE:002317) COGS-to-Revenue : 0.43 (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Guangdong Zhongsheng Pharmaceutical Co COGS-to-Revenue?

Guangdong Zhongsheng Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥275 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥634 Mil.

Guangdong Zhongsheng Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.43.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Guangdong Zhongsheng Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 was 56.58%.

Guangdong Zhongsheng Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Guangdong Zhongsheng Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Zhongsheng Pharmaceutical Co COGS-to-Revenue Chart

Guangdong Zhongsheng Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.33 0.35 0.41 0.44

Guangdong Zhongsheng Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.43 0.46 0.44 0.43

Guangdong Zhongsheng Pharmaceutical Co COGS-to-Revenue Calculation

Guangdong Zhongsheng Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1084.821 / 2467.418
=0.44

Guangdong Zhongsheng Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=275.368 / 634.261
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Zhongsheng Pharmaceutical Co  (SZSE:002317) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Guangdong Zhongsheng Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 275.368 / 634.261
=56.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Guangdong Zhongsheng Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guangdong Zhongsheng Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Zhongsheng Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) » Definitions » COGS-to-Revenue
Comparable Companies
SHSE:600129 SZSE:002675 SZSE:300199 SHSE:600422 SHSE:600993 SZSE:300119 SHSE:600211 SHSE:600572 SZSE:002020 SZSE:300026 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Xihu Industrial Zone, Information Industry Park, Shilong Town, Guangdong Province, Dongguan, CHN, 523325
Website
http://www.zspcl.com
Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It is involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.
Executives
Chen Yong Hong Directors, executives
Zhao Xi Ping Executives
Zhou Xue Li Director
Zhang Yu Chong Secretary, Director
Yin Yuan Yuan Executives
Li Su Xian Supervisors
Long Chun Hua Directors, executives
Ding Chen Huan Supervisors
Li Tao Executives
Cao Jia Yue Supervisors
Zhang Shao Ri Director
Ye Hui Tang Director
Long Chao Feng Directors, executives
Sun Xian Peng Independent director
Huang Shi Bin Supervisors

Guangdong Zhongsheng Pharmaceutical Co Headlines

No Headlines